Skip to main content

Advertisement

Table 1 Demographic and baseline characteristics of participants (safety, pharmacokinetic, and statistical datasets)

From: Relative bioavailability of diazoxide, manufactured at two different international locations, in healthy participants under fasting conditions: an open-label, two-stage, adaptive, sequential two-period crossover study

  N = 36
Age (years), mean ± SD 41 ± 10
Age group, n (%)
 18–40 years 17 (47.2)
 41–64 years 19 (52.8)
Sex, n (%)
 Male 17 (47.2)
 Female 19 (52.8)
Race, n (%)
 Asian 10 (27.8)
 Black 8 (22.2)
 White 18 (50.0)
Ethnicity, n (%)
 Hispanic/Latino 3 (8.3)
BMI (kg/m2), mean ± SD 25.6 ± 2.4
Height (cm), mean ± SD 168.1 ± 8.7
Weight (kg), mean ± SD 72.7 ± 11.5
  1. BMI body mass index, SD standard deviation